97 related articles for article (PubMed ID: 19011332)
1. [Accelerated fractionation].
Shibayama C; Nakazawa M; Nakamura M; Akahane K; Takahashi S; Kashima E
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1837-41. PubMed ID: 19011332
[TBL] [Abstract][Full Text] [Related]
2. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
Horiot JC; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg AC; Pierart M; Collette L
Radiother Oncol; 1997 Aug; 44(2):111-21. PubMed ID: 9288839
[TBL] [Abstract][Full Text] [Related]
3. [Controlled clinical trials of hyperfractionated and accelerated radiotherapy in otorhinolaryngologic cancers].
Horiot JC
Bull Acad Natl Med; 1998; 182(6):1247-60; discussion 1261. PubMed ID: 9812410
[TBL] [Abstract][Full Text] [Related]
4. Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis.
Matuschek C; Haussmann J; Bölke E; Gripp S; Schuler PJ; Tamaskovics B; Gerber PA; Djiepmo-Njanang FJ; Kammers K; Plettenberg C; Anooshahr B; Orth K; Budach W
Radiat Oncol; 2018 Oct; 13(1):195. PubMed ID: 30286777
[TBL] [Abstract][Full Text] [Related]
5. Altered fractionation for head and neck cancer.
Garden AS
Oncology (Williston Park); 2001 Oct; 15(10):1326-32, 1334; discussion 1334, 1339-41. PubMed ID: 11702960
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP;
Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362
[TBL] [Abstract][Full Text] [Related]
8. [Altered fractionation].
Hasegawa M; Nishio M; Myoujin M; Nishiyama N; Ichimura W
Gan To Kagaku Ryoho; 2006 Apr; 33(4):428-35. PubMed ID: 16612149
[TBL] [Abstract][Full Text] [Related]
9. Head and neck cancer: altered fractionation schedules.
Saunders MI
Oncologist; 1999; 4(1):11-6. PubMed ID: 10337367
[TBL] [Abstract][Full Text] [Related]
10. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
[TBL] [Abstract][Full Text] [Related]
11. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer.
Cummings B; Keane T; Pintilie M; Warde P; Waldron J; Payne D; Liu FF; Bissett R; McLean M; Gullane P; O'Sullivan B
Radiother Oncol; 2007 Oct; 85(1):7-16. PubMed ID: 17920715
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
13. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.
Stuschke M; Thames HD
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):259-67. PubMed ID: 9069295
[TBL] [Abstract][Full Text] [Related]
14. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
[TBL] [Abstract][Full Text] [Related]
15. Altered fractionation trials in head and neck cancer.
Ang KK
Semin Radiat Oncol; 1998 Oct; 8(4):230-6. PubMed ID: 9873100
[TBL] [Abstract][Full Text] [Related]
16. Altered fractionation schedules in radiotherapy of head and neck cancer. A review.
Fallai C; Olmi P
Tumori; 1992 Oct; 78(5):311-25. PubMed ID: 1494804
[TBL] [Abstract][Full Text] [Related]
17. [Contribution to survival rate improvement].
Hatano K; Sakai M; Araki H; Imagunbai T
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1833-6. PubMed ID: 19011331
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two different radiation fractionation schedules with concurrent chemotherapy in head and neck malignancy.
Alam MS; Perween R; Siddiqui SA
Indian J Cancer; 2016; 53(2):265-269. PubMed ID: 28071624
[TBL] [Abstract][Full Text] [Related]
19. Hyperfractionation as an altered fractionation regimen in primary radiotherapy for squamous cell carcinoma of the larynx.
Krstevska V; Smichkoska S
Prilozi; 2006 Dec; 27(2):175-87. PubMed ID: 17211301
[TBL] [Abstract][Full Text] [Related]
20. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
Marcu LG
Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
